Cartilage proteoglycan degradation by a mouse transformed macrophage cell line is mediated by macrophage metalloelastase

Inflammation Research

Volumn 48, Issue 5, 1999, Pages 280-288

  Janusz, M J ^a   Hare, M ^a,b   Durham, S L ^a   Potempa, J ^c   McGraw, W ^d   Pike, R ^d   Travis, J ^d   Shapiro, S D ^e  

^a SANOFI   (France)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d UNIVERSITY OF GEORGIA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Cartilage degradation; Macrophage metalloelastase

Indexed keywords

ELASTASE; ELASTIN; MATRIX METALLOPROTEINASE; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PURIFICATION; MACROPHAGE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CARTILAGE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CONNECTIVE TISSUE; CULTURE MEDIA, CONDITIONED; ELASTIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MACROPHAGES; MATRIX METALLOPROTEINASE 12; METALLOENDOPEPTIDASES; MICE; MOLECULAR SEQUENCE DATA; PROTEOGLYCANS;

EID: 0033035182     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050460     Document Type: Article

References (46)

1. [1] Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121-125.
2. [2] Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-54.
3. [3] Krane SM. Clinical importance of metalloproteinases and their inhibitors. In: Greenwald R, Golub LM, editors. Matrix Metalloproteinases: Therapeutic Potential. Ann NY Acad Sci 732: 1-10.
4. [4] Mignatti P, Rifkin D.B. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-95.
5. [5] Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF. Evidence for metalloproteinase and metalloproreinase inbalance in human osteoarthritic cartilage. J Clin Invest 1989; 84: 678-85.
6. [6] Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark M. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992; 35: 35-42.
7. [7] Clark IM, Powell LK, Ramsey S, Hazelman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993; 36: 372-9.
8. [8] Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991; 34: 1076-84.
9. [9] McCachren SS. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 1991; 34: 1085-93.
10. [10] Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986; 261: 6600-05.
11. [11] Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, et al. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 1990; 265 114: 11421-24.
12. [12] Freije JMP, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269: 16766-773.
13. [13] Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 1988; 263: 6579-87.
14. [14] Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV-40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213-21.
15. [15] Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus H. Human 92-and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991; 266: 7870-75.
16. [16] Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4 and 1/4-length fragments. J Biol Chem 1995; 270: 5872-6.
17. [17] Chin JR, Murphy G, Werb Z. Stromelysin b, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. J Biol Chem 1985; 260: 12367-76.
18. [18] Wilhelm SM, Collier IE, Kronberger A, Eisen AZ, Marmer BL, Grant GA, et al. Human skin fibroblast stromelysin: Structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci USA 1987; 84: 6725-9.
19. [19] Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. J Biol Chem 1986: 261: 14245-55.
20. [20] Muller D, Quantin B, Gesnel M-C, Millon-Collard R, Abecassis J, Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J 1988; 253: 187-92.
21. [21] Basset P, Belloeq JP, Wolf C, Stoll I, Hutin P, Limacher JM, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinaomas. Nature 1990; 348: 699-704.
22. [22] Shapiro SD, Griffin GL, Gilbert DJ, Jenkins NA, Copeland NG, Welgus HG, et al. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem 1992; 267: 4664-71.
23. [23] Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastinolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993; 268: 23824-29.
24. [24] Murphy GJP, Murphy G, Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett 1991; 289: 4-7.
25. [25] Henderson B, Pettipher ER. The synovial lining cell: Biology and pathobiology. Semin Arthritis Rheum 1985; 15: 1-32.
26. [26] Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis. Ann Rheum Dis 1989; 48: 645-53.
27. [27] Case JP, Sano R, Lafyatis R, Remmers EF, Kumkumian GK, Wilder RL. Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. J Clin Invest 1989: 84: 1731-40.
28. [28] Case JP, Lafyatis R, Remmers EF, Kumkumian GK, Wilder RL. Transin/stromelysin expression in rheumatoid synovium. Am J Pathol 1989; 135: 1055-64.
29. [29] Matrisian LM, Bowden GT, Kreig P, Furstenberger Briand JP, Leroy P, Breathnach R. The m-RNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci USA 1986; 83: 9413-17.
30. [30] Hamilton JA. Hypothesis: In vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol 1983; 10: 845-51.
31. [31] Brinkerhoff CE, Sheldon LA, Benott MC, Burgess DR, Wilder RL. Effects of retinoids on rheumatic arthritis, a proliferative and invasive nonmalignant disease. Ciba Found Symp 1985; 113: 191-211.
32. [32] Lafyatis R, Remmers EF, Roberts AB, Sporn DE, Wilder RL. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 1989; 83: 1267-76.
33. [33] Fassbender HG, Simmling-Annefeld M. The potential aggressiveness of synovial tissue in rheumatoid arthritis. J Pathol 1983; 139: 399-406.
34. [34] Janusz MJ, Hare M. Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation. J Immunol 1993; 150: 1922-31.
35. [35] Vater, CA, Nagase H, Harris ED Jr. Proactivator-dependent activation of procollagenase induced by treatment with EGTA. Biochem J 1986; 237: 853-8.
36. [36] Steinberg J, Sledge CB, Noble J, Stirrat CR. A tissue-culture model of cartilage breakdown in rheumatoid arthritis. Biochem J 1989; 180: 403-12.
37. [37] Janusz MJ, Doherty NS. Degradation of cartilage matrix proteoglycan by neutrophils involves both elastase and cathepsin G. J Immunol 1991; 146: 3922-8.
38. [38] Banda MJ, Werb Z. Mouse macrophage elastase. Purification and characterization as a metalloproteinase. Biochem J 1981; 193: 589-605.
39. [39] Desrochers PE, Jeffrey JJ, Weiss SJ. Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. J Clin Invest 1991; 87: 2258-65.
40. [40] Shipley M, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD. Metalloelastase is required for macrophage-mediated protcolysis and matrix invasion in mice. Proc Natl Acad Sci USA 1996; 93: 3942-6.
41. [41] Chen Z, Potempa J, Polanowski A, Wikstrom M, Travis J. Purification and characterization of a 50-kDa cysteine proteinase gingi-pain from Porphyromonas gingivalis. J Biol Chem 1992; 267: 18896-901.
42. [42] Chandler S, Cossins J, Lury J, Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumor necrosis factor-α fusion protein. BBRC 1996; 228: 421-9.
43. [43] Gronski TJ, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, et al. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 1997; 272: 12189-94.
44. [44] Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release. Biochem J 1990; 322: 809-14.
45. [45] Chevalier X, Groult N, Texier JM, Larget-Piet B, Hornebeck W. Elastase activity in cartilage extracts and synovial fluids from subjects with osteoarthritis or rheumatoid arthritis: the prominent role of metalloproteinases. Clin Exper Rheum 1996; 14: 235-41.
46. [46] Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 1997; 94: 2150-5.